Medi-Caps Ltd.

As of June 30, 2026, Medi-Caps Ltd. carries a market capitalization of 331.58M, placing it among publicly traded companies globally. Its enterprise value stands at 331.58M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2026, Medi-Caps Ltd. has 12.47M shares outstanding.

These figures are as of June 30, 2026.

These figures are as of June 30, 2026. The EV/Sales ratio of 2.67 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 331.58M versus a market cap of 331.58M, with the gap driven by net debt and cash on the balance sheet.

These figures cover the twelve months ended June 30, 2026. The company generates approximately 13.82M in revenue per employee across its workforce of 9.00, a quick read on workforce productivity versus industry peers.

Over the twelve months ended June 30, 2026, Medi-Caps Ltd. recorded 141,000.00 in income tax expense. The company reported a pretax loss of -17.64M and -17.78M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

As of the close on October 23, 2026, Medi-Caps Ltd.'s stock has declined approximately 35.01% over the past 52 weeks. The 50-day moving average sits at 26.33, while the 200-day moving average is 26.99.

Over the twelve months ended June 30, 2026, Medi-Caps Ltd. generated 124.36M in revenue and converted that into -17.78M in net income, yielding earnings per share of -1.42. EBITDA reached -78.65M, while operating income came in at -96.89M.

Over the twelve months ended June 30, 2026, Medi-Caps Ltd. posted a gross margin of 57.09, reflecting its pricing power and cost economics. The operating margin of -77.91 and net profit margin of -14.30 provide insight into operational efficiency.

Medi-Caps Ltd.'s most recent stock split took place on March 19, 2013 with a 1:4 split ratio.